NCT02197364View on ClinicalTrials.gov

The Role of KL-6 in the Clinical Diagnosis of ILD

CompletedOBSERVATIONAL
Enrollment

1,190

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Interstitial Lung Disease
Sponsors
All Listed Sponsors
collaborator

Fujirebio Diagnostics, Inc.

INDUSTRY

lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER